Grin Therapeutics, Inc.
Clinical trials sponsored by Grin Therapeutics, Inc., explained in plain language.
-
New drug trial offers hope for controlling severe genetic brain disorder
Disease control Recruiting nowThis study is testing an investigational drug called radiprodil in people with GRIN-related neurodevelopmental disorder, a rare genetic condition that causes seizures and developmental challenges. The trial aims to see if radiprodil can reduce seizure frequency and improve daily …
Phase: PHASE3 • Sponsor: GRIN Therapeutics, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
First safety test for new brain drug in people with liver issues
Knowledge-focused Recruiting nowThis early-stage study aims to understand how a potential new drug called radiprodil is processed by the body in people with different levels of liver impairment. The drug is being developed for certain genetic brain disorders. About 40 adults, some with liver problems and some h…
Phase: PHASE1 • Sponsor: GRIN Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC